Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Sun Pharmaceutical Industries Ltd.
Source DateBoard Meeting DateDetails
16-Jan-2025 31-Jan-2025 Quarterly Results & Interim Dividend
09-Oct-2024 28-Oct-2024 Quarterly Results
15-Jul-2024 01-Aug-2024 Quarterly Results
13-May-2024 22-May-2024 Final Dividend & Audited Results
15-Jan-2024 31-Jan-2024 Interim Dividend & Quarterly Results
13-Oct-2023 01-Nov-2023 Quarterly Results
11-Jul-2023 03-Aug-2023 Quarterly Results
11-May-2023 26-May-2023 Final Dividend & Audited Results
16-Jan-2023 31-Jan-2023 Quarterly Results & Interim Dividend
10-Oct-2022 01-Nov-2022 Quarterly Results
12-Jul-2022 29-Jul-2022 Quarterly Results
12-May-2022 30-May-2022 Final Dividend & Audited Results
17-Jan-2022 31-Jan-2022 Interim Dividend
12-Oct-2021 02-Nov-2021 Quarterly Results
13-Jul-2021 30-Jul-2021 Quarterly Results
10-May-2021 27-May-2021 Final Dividend & Audited Results
04-Jan-2021 29-Jan-2021 Quarterly Results
21-Oct-2020 03-Nov-2020 Quarterly Results
27-Jul-2020 31-Jul-2020 Quarterly Results
18-May-2020 27-May-2020 Final Dividend & Audited Results
Page 1 of 6
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.